🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Assessing Health System Readiness for Scaling Antenatal MMS in Cambodia

Recruitingn/aAges 18 Years - anyFemaleUniversity of British Columbia
NCT07400796 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Malnutrition among pregnant women in low- and middle-income countries (LMICs) can cause micronutrient deficiencies that result in adverse maternal and neonatal health outcomes. The World Health Organization has recently recommended antenatal multiple micronutrient supplementation (MMS) that includes iron and folic acid (IFA) to improve maternal and neonatal health outcomes. MMS likely provides additional antenatal benefits over IFA supplementation alone. The Cambodian government, in partnership with Helen Keller International, is piloting MMS implementation in Takeo Province, which will inform nationwide scale-up of MMS. Study Purpose: The Takeo implementation must be evaluated to understand context-specific implementation of MMS and health system readiness for scale-up. This study assesses system readiness through four domains from the Intervention Scalability Assessment Tool (ISAT): (

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
For the cohort of pregnant individuals consuming MMS: Inclusion Criteria: * Current pregnant * At least 18 years of age * Have attended at least one ANC visit at a health center or hospital in Takeo during the study period * Can provide a functioning phone number for follow-up contact * Willingness to participate and provide consent Exclusion Criteria: * Individuals with diagnosed anemia who require iron and folic acid (IFA) supplementation instead of MMS * Individuals unable to communicate via telephone,;(3) individuals who withdraw consent at any point
💊

What it tests

  • Multiple micronutrient supplement (MMS) for pregnancy
📍

Where

1 site
Takeo province
Phnom Penh, Cambodia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy